Secretary Kennedy Appoints New Interagency Autism Coordinating Committee to Advance Fight Against Autism
HHS announces 21 new IACC members committed to breakthrough innovations in autism research, diagnosis, treatment, and prevention—signaling a major shift toward biomedical and integrative approaches.
Key Highlights
The Announcement
The U.S. Department of Health and Human Services (HHS) today announced the appointment of 21 new members to the Interagency Autism Coordinating Committee (IACC). These appointments reflect Secretary Robert F. Kennedy, Jr.'s commitment to support breakthrough innovations in autism research, diagnosis, treatment, and prevention.
"President Trump directed us to bring autism research into the 21st century. We are doing that by appointing the most qualified experts—leaders with decades of experience studying, researching, and treating autism. These public servants will pursue rigorous science and deliver the answers Americans deserve."
Why This Matters for Regenerative Medicine
This historic appointment signals a paradigm shift in how autism research and treatment will be approached at the federal level. Many of the newly appointed members have backgrounds in:
- Integrative and biomedical approaches to autism care
- Gut microbiome and immune system research related to autism
- Environmental factors and their role in autism development
- Personalized medicine and systems-biology approaches
At BetterStem, we've long advocated for exploring innovative therapies, including mesenchymal stem cell (MSC) treatments, that address the biological underpinnings of autism. This new IACC composition suggests increased openness to rigorous investigation of regenerative and biological interventions.
Medical & Research Experts Appointed
Sylvia Fogel, M.D.
Instructor in Psychiatry, Harvard Medical School
Practicing psychiatrist applying systems biology and family-informed perspectives to advance care for individuals with ASD. Works with the Autism Innovation Coalition and serves on the Massachusetts PANDAS/PANS Advisory Committee. Parent of a child with profound autism and PANS.
Daniel Rossignol, M.D., FAAFP
Chief Medical Officer, Autism Discovery and Treatment Foundation
Board-certified family physician and clinician-researcher advancing personalized, systems-biology approaches. Has authored 80+ publications and co-edited "A Personalized Medicine Approach to the Diagnosis and Management of Autism Spectrum Disorder." Past President of MAPS. Father of two children with autism.
Elizabeth Mumper, M.D.
Founder & CEO, Rimland Center for Integrative Medicine
Board-certified pediatrician and former medical director of the Autism Research Institute. Published scholarly works on autism's interactions with cytotoxicity, inflammation, methylation, and hyperbaric treatment.
Elena Monarch, Ph.D.
CEO & Neuropsychologist, Lyme and PANS Treatment Center
Conducted NIH-funded research into biopsychosocial interventions. Ph.D. in Clinical Psychology from Emory University with emphasis on neuropsychology, cognition, and development.
Walter Zahorodny, Ph.D.
Associate Professor of Pediatrics, Rutgers - New Jersey Medical School
Directed the New Jersey Autism Study for 20+ years in partnership with the CDC. Developed "Autism Detection + Connection" system for early autism identification.
Toby Rogers, Ph.D., M.P.P.
Fellow, Brownstone Institute for Social and Economic Research
Doctoral thesis "The Political Economy of Autism" explores regulatory history of toxicants that increase autism risk. Recently presented research at U.S. Senate hearing.
Autistic Self-Advocates Appointed
In a historic move, the new IACC includes non-speaking autistic adults who communicate through spelling and typing—ensuring that the voices of those most affected by autism policy are heard directly.
Caden Larson
Non-speaking adult studying mathematics at Normandale Community College. Board member of Children with Autism Deserve Education (CADE).
Elizabeth Bonker
Executive Director of Communication 4 ALL. Travels worldwide to empower nonspeakers with communication and education. Past co-chair of the Autism Taskforce.
Daniel Keely
High school senior, FAA-licensed remote pilot since age 14. Diagnosed at age 3 with autism and began speaking in second grade. Author of "The Folate Fix."
Parent Advocates & Nonprofit Leaders
John Rodakis
Founder, N of One: Autism Research Foundation. Harvard MBA. Partnered with Harvard & Johns Hopkins on clinical trials.
Laura Cellini
25+ years legislative experience. Son recovered from severe regressive autism to magna cum laude college graduate.
Jennifer Philips
Founder, Make A Stand 4 Autism. 13+ years advocating since daughter's regression into profound autism.
John Gilmore, M.P.P.
Founder, Autism Action Network. 100,000+ subscribers. UC Berkeley M.P.P.
Lisa Wiederlight, M.P.P.
Led passage of Kevin and Avonte's Law. Established Maryland's first State Autism Coordinator.
Lisa Ackerman
Co-founder, TACA. Served 100,000+ parents. Raised $37M for family programs, $5M for research.
Tracy Slepcevic
U.S. Air Force veteran. Founder, Autism Health Summit. Author of "Warrior Mom."
Katie Sweeney
TEDxBroadway speaker. Parent of profoundly autistic, non-speaking adult. Cornell MBA.
Organization Leaders
Honey Rinicella
Executive Director, MAPS
Operates the only formal physician fellowship in the U.S. for autism care. Parent of 25-year-old twins with autism.
Krystal Higgins
Executive Director, NAA
Former special educator. Served on DoD autism panel. Certified S2C practitioner.
Bill Oldham
Founder, TLI Foundation
2025 Philadelphia Titan 100. Founded Autism First family support organization.
Ginger Taylor, M.S.
Parent Advocate
Former family therapist. Johns Hopkins M.S. Focus on parental rights and informed consent.
What This Means for Autism Families
Research Direction
Expect increased focus on biological mechanisms, including immune dysfunction, gut microbiome, and environmental factors.
Treatment Innovation
Greater openness to investigating integrative, personalized, and biomedical treatment approaches.
Communication Access
Strong advocacy for spelling/typing-based communication methods for non-speaking individuals.
Family-Centered
Multiple parent advocates with lived experience ensuring family perspectives shape policy.
BetterStem's Commitment
At BetterStem, we welcome this shift toward rigorous, science-based exploration of biological interventions for autism. Our work in mesenchymal stem cell therapy aligns with the IACC's new direction of investigating the underlying biological mechanisms of autism spectrum disorder.
Our team of experts continues to monitor developments in autism research and policy, ensuring our patients and families have access to the latest evidence-based information.
Sources & References
- • U.S. Department of Health and Human Services Official Announcement (January 28, 2026)
- • Interagency Autism Coordinating Committee (IACC) - Official Website
- • Individual appointee organizational affiliations and published works